Another thing to consider is that our industry is in decline - it's shrinking! There are half as many pharmaceutical reps in the industry today vs 10 years ago. It's all moving toward specialty drugs and rare disease drugs. That's where it's been heading and will continue to go. Large sales forces are not needed for selling specialty and rare disease drugs. Territory geographies are typically quite large. And in selling in these spaces usually requires an "account-based" selling style which is not the typical "metrics-oriented" pharma selling style. In my last job, a specialty position where we did account-based selling, if I met with one or two docs in a day, or a nurse manager, that would be considered a productive day. It was not about how many calls you made per day, it was about "did you advance the sale?". A lot of work was done at home (phone calls, setting up appointments, etc.) and behind the scenes. The reality is that as the industry shrinks there will be less and less rep jobs available - large numbers of reps simply are not needed. And those that remain will have competed for fewer and fewer jobs. And those jobs will more and more be specialty positions that involve account-based selling. And those jobs are not easy to secure - companies can afford to be very selective and they will be (note: currently there is an over-supply of experienced pharma reps in the job market). Contract work will continue, but will remain as unstable as ever. Many reps will be forced out of the industry eventually. Read this recent article I have linked here to gain more insight as to where we are headed as an industry:
https://endpts.com/pharmas-broken-business-model-an-industry-on-the-brink-of-terminal-decline/